Henry Schein Inc (HSIC) Stock AnalysisHSICHenry Schein Inc

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc is a good buy right now due to its solid financial performance and positive market sentiment. The current price is $89.52, and the company reported a strong Q2 with a net income of $94 million and an EPS of $0.82, up from $0.70 last year. Additionally, the forward P/E ratio of 17.51 indicates attractive valuation relative to future earnings. However, the main risk is the debt to equity ratio, which is currently at 90.70%, indicating a high level of debt that could impact financial stability if not managed well.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.